Global Genomic Biomarker Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Genomic Biomarker Revenue
• 1.4 Market by Type
  • 1.4.1 Global Genomic Biomarker Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Oncology
  • 1.4.3 Cardiology
  • 1.4.4 Neurology
  • 1.4.5 Nephrology
• 1.5 Market by Application
  • 1.5.1 Global Genomic Biomarker Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Diagnostic and research laboratories
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Genomic Biomarker Market Perspective (2015-2026)
• 2.2 Global Genomic Biomarker Growth Trends by Regions
  • 2.2.1 Genomic Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Genomic Biomarker Historic Market Share by Regions (2015-2020)
  • 2.2.3 Genomic Biomarker Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Genomic Biomarker Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Genomic Biomarker Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Genomic Biomarker Players by Market Size
  • 3.1.1 Global Top Genomic Biomarker Players by Revenue (2015-2020)
  • 3.1.2 Global Genomic Biomarker Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Genomic Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Genomic Biomarker Market Concentration Ratio
  • 3.2.1 Global Genomic Biomarker Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Genomic Biomarker Revenue in 2019
• 3.3 Genomic Biomarker Key Players Head office and Area Served
• 3.4 Key Players Genomic Biomarker Product Solution and Service
• 3.5 Date of Enter into Genomic Biomarker Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Genomic Biomarker Historic Market Size by Type (2015-2020)
• 4.2 Global Genomic Biomarker Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Genomic Biomarker Market Size by Application (2015-2020)
• 5.2 Global Genomic Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Genomic Biomarker Market Size (2015-2020)
• 6.2 Genomic Biomarker Key Players in North America (2019-2020)
• 6.3 North America Genomic Biomarker Market Size by Type (2015-2020)
• 6.4 North America Genomic Biomarker Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Genomic Biomarker Market Size (2015-2020)
• 7.2 Genomic Biomarker Key Players in Europe (2019-2020)
• 7.3 Europe Genomic Biomarker Market Size by Type (2015-2020)
• 7.4 Europe Genomic Biomarker Market Size by Application (2015-2020)

8 China

• 8.1 China Genomic Biomarker Market Size (2015-2020)
• 8.2 Genomic Biomarker Key Players in China (2019-2020)
• 8.3 China Genomic Biomarker Market Size by Type (2015-2020)
• 8.4 China Genomic Biomarker Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Genomic Biomarker Market Size (2015-2020)
• 9.2 Genomic Biomarker Key Players in Japan (2019-2020)
• 9.3 Japan Genomic Biomarker Market Size by Type (2015-2020)
• 9.4 Japan Genomic Biomarker Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Genomic Biomarker Market Size (2015-2020)
• 10.2 Genomic Biomarker Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Genomic Biomarker Market Size by Type (2015-2020)
• 10.4 Southeast Asia Genomic Biomarker Market Size by Application (2015-2020)

11 India

• 11.1 India Genomic Biomarker Market Size (2015-2020)
• 11.2 Genomic Biomarker Key Players in India (2019-2020)
• 11.3 India Genomic Biomarker Market Size by Type (2015-2020)
• 11.4 India Genomic Biomarker Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Genomic Biomarker Market Size (2015-2020)
• 12.2 Genomic Biomarker Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Genomic Biomarker Market Size by Type (2015-2020)
• 12.4 Central & South America Genomic Biomarker Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Bio-Rad
  • 13.1.1 Bio-Rad Company Details
  • 13.1.2 Bio-Rad Business Overview
  • 13.1.3 Bio-Rad Genomic Biomarker Introduction
  • 13.1.4 Bio-Rad Revenue in Genomic Biomarker Business (2015-2020))
  • 13.1.5 Bio-Rad Recent Development
• 13.2 Beckman Coulter
  • 13.2.1 Beckman Coulter Company Details
  • 13.2.2 Beckman Coulter Business Overview
  • 13.2.3 Beckman Coulter Genomic Biomarker Introduction
  • 13.2.4 Beckman Coulter Revenue in Genomic Biomarker Business (2015-2020)
  • 13.2.5 Beckman Coulter Recent Development
• 13.3 Myriad Genetics
  • 13.3.1 Myriad Genetics Company Details
  • 13.3.2 Myriad Genetics Business Overview
  • 13.3.3 Myriad Genetics Genomic Biomarker Introduction
  • 13.3.4 Myriad Genetics Revenue in Genomic Biomarker Business (2015-2020)
  • 13.3.5 Myriad Genetics Recent Development
• 13.4 Thermo Fisher Scientific
  • 13.4.1 Thermo Fisher Scientific Company Details
  • 13.4.2 Thermo Fisher Scientific Business Overview
  • 13.4.3 Thermo Fisher Scientific Genomic Biomarker Introduction
  • 13.4.4 Thermo Fisher Scientific Revenue in Genomic Biomarker Business (2015-2020)
  • 13.4.5 Thermo Fisher Scientific Recent Development
• 13.5 Roche
  • 13.5.1 Roche Company Details
  • 13.5.2 Roche Business Overview
  • 13.5.3 Roche Genomic Biomarker Introduction
  • 13.5.4 Roche Revenue in Genomic Biomarker Business (2015-2020)
  • 13.5.5 Roche Recent Development
• 13.6 QIAGEN
  • 13.6.1 QIAGEN Company Details
  • 13.6.2 QIAGEN Business Overview
  • 13.6.3 QIAGEN Genomic Biomarker Introduction
  • 13.6.4 QIAGEN Revenue in Genomic Biomarker Business (2015-2020)
  • 13.6.5 QIAGEN Recent Development
• 13.7 Epigenomics
  • 13.7.1 Epigenomics Company Details
  • 13.7.2 Epigenomics Business Overview
  • 13.7.3 Epigenomics Genomic Biomarker Introduction
  • 13.7.4 Epigenomics Revenue in Genomic Biomarker Business (2015-2020)
  • 13.7.5 Epigenomics Recent Development
• 13.8 Almac
  • 13.8.1 Almac Company Details
  • 13.8.2 Almac Business Overview
  • 13.8.3 Almac Genomic Biomarker Introduction
  • 13.8.4 Almac Revenue in Genomic Biomarker Business (2015-2020)
  • 13.8.5 Almac Recent Development
• 13.9 Pfizer
  • 13.9.1 Pfizer Company Details
  • 13.9.2 Pfizer Business Overview
  • 13.9.3 Pfizer Genomic Biomarker Introduction
  • 13.9.4 Pfizer Revenue in Genomic Biomarker Business (2015-2020)
  • 13.9.5 Pfizer Recent Development
• 13.10 Human Longevity
  • 13.10.1 Human Longevity Company Details
  • 13.10.2 Human Longevity Business Overview
  • 13.10.3 Human Longevity Genomic Biomarker Introduction
  • 13.10.4 Human Longevity Revenue in Genomic Biomarker Business (2015-2020)
  • 13.10.5 Human Longevity Recent Development
• 13.11 ValiRx
  • 10.11.1 ValiRx Company Details
  • 10.11.2 ValiRx Business Overview
  • 10.11.3 ValiRx Genomic Biomarker Introduction
  • 10.11.4 ValiRx Revenue in Genomic Biomarker Business (2015-2020)
  • 10.11.5 ValiRx Recent Development
• 13.12 Personalis
  • 10.12.1 Personalis Company Details
  • 10.12.2 Personalis Business Overview
  • 10.12.3 Personalis Genomic Biomarker Introduction
  • 10.12.4 Personalis Revenue in Genomic Biomarker Business (2015-2020)
  • 10.12.5 Personalis Recent Development
• 13.13 Eagle Genomics
  • 10.13.1 Eagle Genomics Company Details
  • 10.13.2 Eagle Genomics Business Overview
  • 10.13.3 Eagle Genomics Genomic Biomarker Introduction
  • 10.13.4 Eagle Genomics Revenue in Genomic Biomarker Business (2015-2020)
  • 10.13.5 Eagle Genomics Recent Development
• 13.14 Empire Genomics
  • 10.14.1 Empire Genomics Company Details
  • 10.14.2 Empire Genomics Business Overview
  • 10.14.3 Empire Genomics Genomic Biomarker Introduction
  • 10.14.4 Empire Genomics Revenue in Genomic Biomarker Business (2015-2020)
  • 10.14.5 Empire Genomics Recent Development
• 13.15 Agilent
  • 10.15.1 Agilent Company Details
  • 10.15.2 Agilent Business Overview
  • 10.15.3 Agilent Genomic Biomarker Introduction
  • 10.15.4 Agilent Revenue in Genomic Biomarker Business (2015-2020)
  • 10.15.5 Agilent Recent Development
• 13.16 Illumina
  • 10.16.1 Illumina Company Details
  • 10.16.2 Illumina Business Overview
  • 10.16.3 Illumina Genomic Biomarker Introduction
  • 10.16.4 Illumina Revenue in Genomic Biomarker Business (2015-2020)
  • 10.16.5 Illumina Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer